The wire › SEC Form 8-K
InMed Pharmaceuticals Inc. INM
Filed with the SEC on Sep 18, 2026. Reported event date Sep 16, 2026.
- Business address
- Vancouver
- State
- Outside the U.S. or not given
- Incorporated in
- Outside the U.S. or not given
- Industry
- Manufacturing (SIC 2834)
- SEC CIK
- 1728328
- Accession number
- 0001213900-26-101492
Items reported in this filing
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
- Item 8.01 Other Events
- Item 9.01 Financial Statements and Exhibits
Other entries on the wire for this company
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing